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Gold(III) complexes, isostructural and isoelectronic with plati-
num(II) complexes, are of potential interest as antitumor drugs.
We prepared four representative square planar gold(III) complexes
– AuCl3(Hpm), AuCl2(esal), AuCl(dien)Cl2 and Au(en)2Cl3 –
and characterized them both in the solid state and in solution.
Thereafter, the cytotoxicity of these compounds was evaluated in
vitro against the A2780 human ovarian tumor cell line that was
used as the reference cell line. Remarkably, all these gold(III) com-
plexes showed significant cytotoxic effects, AuCl2(esal) showing a
potency comparable to cisplatin. The present gold(III) complexes
were also tested on the corresponding cisplatin-resistant line and
revealed they were able to overcome resistance to cisplatin to a
large extent. The implications of these findings for the develop-
ment of new gold(III) complexes to be tested as antitumor agents
are discussed.
Key words: gold complexes, X-ray structure, antitumoral compounds,
cytotoxicity.
INTRODUCTION
The success of cisplatin in anticancer chemotherapy has raised great in-
terest in the study of metal complexes as possible antitumor agents. The
main goals of the intense research activity carried out in the field are the
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following: i) search for new metal based anticancer drugs; ii) understanding
of their mechanism of action.
Within this frame we have synthesized in our laboratory a number of
gold(III) complexes to be tested for antitumor activity in vitro. The choice of
gold(III) derives from the fact that this ion gives rise to complexes that are
isoelectronic and isostructural with those of platinum(II), whose antitumor
activity is well established.1 Surprisingly, in spite of the strict chemical
similarity, only very few literature data exist on the use of gold(III) com-
plexes as anticancer agents. The present knowledge of the antitumor prop-
erties of gold(III) complexes was summarized by Sadler.2 From the few data
available, and by analogy with the case of platinum(II) complexes, it is hy-
pothesized that the biological action of gold(III) compounds is mediated by a
direct interaction with DNA.2 For instance, trichloropyridine gold(III) was
reported to react with a number of different conformations of pBR322 DNA
and to produce interstrand cross links and single strand breaks;3 Et3PAuBr3
is known to bind Hind III/Ncil, a 139 base pair restriction fragment from
pBR322.4
For a preliminary evaluation of the cytotoxic properties of these com-
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Figure 1. Schematic drawings of the complexes: a) AuCl3(Hpm), b) AuCl2(esal),
c) AuCl(dien)Cl2, and d) Au(en)2Cl3.
chemical properties in the solid state and in solution and evaluated their
cytotoxic activity in vitro towards the A2780 human ovarian carcinoma cell
line.
All the mentioned complexes essentially correspond to a square planar
geometry but have different sets of donor atoms (Figure 1). The AuCl3(Hpm)
contains three chlorides coordinated to the gold(III) center; AuCl2(esal)
contains two coordinated chlorides, AuCl(dien)Cl2 a single coordinated
chloride and Au(en2)Cl3 no coordinated chlorides. In all cases, the remain-
ing donors are nitrogen atoms – except for AuCl2(esal), which has a nitro-
gen and an oxygen – belonging either to amine groups or to heterocycles.
Thus, one of the main goals of the present research is to establish whether
any direct correlation exists between the nature of the gold(III) ligands and
the cytotoxic properties of these compounds.
EXPERIMENTAL
Synthesis of the Compounds
The gold(III) complex AuCl3(Hpm) was synthesized according to the reported
procedure:5 a solution of 2-pyridylmethanol in water was added dropwise to a stirred
solution of NaAuCl4 and sodium chloride in water at 0 °C. A yellow solid,
AuCl3(Hpm), separated immediately; the stirring went on for 45 minutes. The pu-
rity of the resulting products was tested through elemental analysis. The
AuCl2(esal) was synthesized according to the reported procedure as well:5 a solu-
tion of NaAuCl4 in water was cooled to about –5 °C. To this solution, N-ethylsalicyl-
aldimine dissolved in methanol was added dropwise under stirring during 5–10 min.
The mixture became cloudy mustard-brown and was allowed to stand in the refrig-
erator for a week. The upper aqueous layer was decanted from the dark oil which
had formed. Chlorobenzene was added to the oil, much of which dissolved to give a
purple solution. This solution was evaporated in vacuum to a small volume and then
addition of diethyl ether gave a green-blue precipitate of the complex AuCl2(esal).
The AuCl(dien)Cl2 was prepared according to Ref. 6; the Au(en2)Cl3 was prepared
according to Ref. 7.
X-ray Crystallography
All data for AuCl3(Hpm) and AuCl2(esal) were collected on an Enraf-Nonius
CAD4 diffractometer with graphite-monochromated Cu-K radiation ( = 1.54180 Å)
at room temperature. Cell parameters were obtained from 25 well-centered reflec-
tions by using least-square refinement. The absorption correction was done with the
program PSISCAN included in the Enraf-Nonius Structure Determination Package.8
The structures were solved using direct methods and successive difference Fourier
synthesis. All non-hydrogen atoms were refined anisotropically and hydrogen atoms
were placed in the calculated position and refined isotropically. The calculations
were carried on with the SIR929 and SHELXL9310 programs.
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Cytotoxicity
For cytotoxicity studies, the human ovarian carcinoma A2780/S cell line was
used. The cisplatin resistant A2780/R cell line was produced by exposure of the sen-
sitive parental cell lines to incremental concentrations of cisplatin and was main-
tained in culture with 10 and 50 M CDDP, respectively. Cell lines were maintained
in RPMI 1640 medium supplemented with fetal bovine serum and antibiotics at 37
°C in a 5% CO2 atmosphere and subcultured twice weekly. Experiments were con-
ducted on exponentially growing cells. The SRB assay was conducted in 96-well
plates using RPMI 1640 + 5% FBS. The SRB assay was performed according to the
procedure described by Skehan et al.11
RESULTS
Structural Description of the Investigated Gold(III) Complexes
The crystal structures of AuCl(dien)Cl2 and Au(en)2Cl3 were previ-
ously solved by other groups and are available in the literature.6,7 The crys-
tal structures of AuCl3(Hpm) and AuCl2(esal) have been solved in our
laboratory and published separately.12,13 ORTEP views of these latter com-
plexes are shown in Figure 2. All gold(III) complexes considered in this stu-
dy essentially exhibit a square planar geometry with small distortions from
regularity. Au–Cl and Au–N distances fall in the expected range Au–Cl (av)
= 2.274 Å; Au–N (av) 2.031 Å. In AuCl3(Hpm) the coordination plane
makes an angle of 73.0° with the pyridine ring, a position that minimizes
the repulsion energy. The coordination plane in AuCl2(esal) is not coplanar
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Figure 2. ORTEP diagrams of the complexes: a) AuCl2(esal) and b) AuCl3(Hpm).
The ellipsoids show 50% of probability.
with the aromatic moiety of the salicylaldiminate ligand either, the angle
being 152°. Interestingly enough, in AuCl(dien)Cl2 gold(III) coordination is
completed by two chlorides at 3.12 and 3.18 Å.
Solution Properties
The Au(en)2Cl3 and AuCl(dien)Cl2 are fairly soluble in water; in con-
trast, AuCl3(Hpm) and AuCl2(esal) are poorly soluble in water but dis-
solve easily in DMSO. The stability of the four complexes in a physiological
buffer was investigated spectrophotometrically. In fact, all complexes ex-
hibit characteristic ligand to metal charge transfer bands in the visible re-
gion, which allow direct monitoring of the gold(III) chromophore. It is ob-
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Figure 3. UV spectra of Au(en)2Cl3 and AuCl(dien)Cl2 in physiological buffer a) at
mixing, and b) after one hour.
served that Au(en)2Cl3 and AuCl(dien)Cl2 are stable for several hours
when dissolved within a physiological buffer (Figure 3); in contrast,
AuCl3(Hpm) and AuCl2(esal), which are quite stable in DMSO, undergo
quick transformation and degradation when dissolved in the same buffer.14
Cytotoxic Properties
The cytotoxic properties of the four complexes were analyzed with re-
spect to the A2780 human ovarian carcinoma cell line, either sensitive or re-
sistant to cisplatin. The results are shown in Figure 4 and Table I. All com-
plexes exhibit significant cytotoxic properties with IC50 values falling in the
5–15 micromolar range. The order of potency shown by the four complexes is
the following: AuCl2(esal) > Au(en)2Cl3 > AuCl(dien)Cl2 > AuCl3(Hpm).
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Figure 4. Cytotoxicity curves of the various gold(III) complexes.
TABLE I
IC50 values for the listed complexes: average data of 3 experiments
Au(Hpm) Au(esal) Au(dien) Au(en)2 CDDP
A2780/S 10.1  1.0 2.1  0.7 8.2  1.3 8.4  1.1 1.6  1.3
A2780/R 21.0a 3.8  1.4 18.7  3.0 17.0  6.0 16.1  8.7
Ratio R/S 2.08 1.81 2.28 2.02 10.06
a 2 experiments only.
Remarkably, all complexes exhibit favorable cytotoxic properties toward the
cisplatin resistant cell line. The decrease in sensitivity to gold(III) com-
plexes when passing from the A2780S to the A2780R line is on average less
than a factor two whereas sensitivity to cisplatin decreases by more than
one order of magnitude.
DISCUSSION AND CONCLUSIONS
Gold(III) complexes, isostructural and isoelectronic with Pt(II) com-
pounds, are potentially attractive as antitumor agents. Given the strict si-
milarity to cisplatin, gold(III) complexes are of interest for two main rea-
sons: on the one side, they may constitute a new class of anticancer
compounds with a novel profile of antitumor activity; on the other side, they
represent a further attempt to elucidate the mechanism of action of antitu-
mor d8 square planar metal complexes, which still remains largely unknown.
In this context, it is of fundamental importance to determine to what extent
gold(III) compounds are cytotoxic and to define their structure-function re-
lationships. Previous investigations had already revealed favorable cyto-
toxic properties for some gold(III) complexes; however, the data present in
the literature are still very scarce, probably as a consequence of the high re-
activity of gold(III) complexes.
In any case, the evaluation of the cytotoxic properties of a series of
gold(III) compounds synthesized in our laboratory has provided satisfactory
and even surprising results. Indeed, analysis of the activity profiles sug-
gests that in some cases the intrinsic cytotoxicity of the present compounds
is comparable to or only slightly lower than that of cisplatin (IC50 values in
the 1–10 M range). In some cases, these compounds exhibit a cytotoxic ac-
tion that even exceeds that of cisplatin itself. Since all the investigated com-
plexes exhibit IC50 values roughly falling within a single order of magni-
tude, it may be ruled out that there is a direct correlation between the
number of gold-coordinated chloride groups and the cytotoxic effects. In
fact, either AuCl(dien)Cl2 or Au(en)2Cl3 bearing only a single or no gold
coordinated chloride exhibit cytotoxic properties comparable to those of
AuCl3(Hpm) and AuCl2(esal) with two or three gold(III) coordinated chlo-
rides. Such a finding allows us to state that the presence of one or more
gold(III) coordinated halides is not an essential requirement for cytotoxcity
in gold(III) complexes. Apparently, more complex effects are responsible for
the observed biological acitivity. In addition, it has been recently reported14
that the gold(III) complex Au(cyclam)(ClO4)2Cl containing four nitrogen
donor atoms is virtually devoid of cytotoxicity toward the same tumor cell
line. Even the favorable cytotoxic properties of AuCl2(esal) are a surprise
if one considers the high chemical reactivity of this compound. Indeed, un-
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der physiological conditions, AuCl2(esal) readily hydrolyzes and partially
transforms into a reduced gold(I) species. The fact that the measured cyto-
toxicity is nevertheless relevant may imply that this complex either re-
mains in part as a gold(III) species and is quickly taken up by cells as such
or that one of its metabolites is highly cytotoxic.
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SA@ETAK
Struktura i citotoksi~na svojstva nekih izabranih
zlatovih(III) kompleksa
Bruno Bruni, Annalisa Guerri, Giordana Marcon, Luigi Messori i Pierluigi Orioli
Zlatovi(III) kompleksi koji su izostrukturni i izoelektronski s platinskim(II)
kompleksima potencijalni su antitumorni lijekovi. Prire|ena su ~etiri tipi~na
kompleksa trovalentnog zlata kvadratne koordinacije – AuCl3(Hpm), AuCl2(esal),
AuCl(dien)Cl2 and Au(en)2Cl3 – i potanko prou~ena, kako u kristalnom stanju ta-
ko i u otopini. Nadalje, citotoksi~nost tih spojeva procijenjena je in vitro na ljudskim
tumornim stanicama jajnika A2780 koje su bile kori{tene kao referentna skupina
stanica. Znakovito je da su svi ti zlatovi(III) kompleksi pokazivali znatne citotok-
si~ne u~inke od kojih je AuCl2(esal) pokazivao djelovanje usporedljivo onom cispla-
tina. Kada su zlatovi(III) kompleksi bili ispitani na odgovaraju}oj skupini stanica
koje su bile rezistentne na cisplatin, rezultati su znatno prema{ivali otpornost pre-
ma cisplatinu. Raspravlja se o zna~enju rezultata ovih istra`ivanja na razvoj novih
kompleksa trovalentnog zlata koji bi se mogli uporabiti kao antitumorni agensi.
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